Home
About Us
Our Vision & Mission
Who We Are
Our History
Message from CMD-Desk
Our Leadership
People and Values
Our Values
Testimonials
Our Major Accreditations
Meet Our Team
Our Partners
Our Business
Ethical Business
Generic Healthcare Business
Export Business
Research & Development
Products
Ethical
Allopathic Medicine
General Health
Gynaecology
Pediatric
Ayurvedic Medicine
Generic
Agile
Healthcare
Capacities
Quality
Manufacturing
Global Business Unit
Samba Unit
Research & Development
Investor Relations
Disclosure under Regulation 46
Details of Business
MOA
Brief Profile of Directors
Composition of BOD
Composition of Committees
Corporate Goverance
Notice of Board Meetings
Financial Results (Quarterly)
Credit Rating
Audited Financial Results of Subsidiaries
Annual Returns
Notice of AGM/EGM
Notices
Annual Reports
Voting Results
Transcript
Business Responsiblity Reports
Shareholders Information
Shareholder Services
Unclamied Dividend
Details of Transfer under SEBI Circular
Amalgamation
Preferential Issue
Corporate Announcements
Integrated Corporate Goverance
Shareholding Pattern
Other Announcements
Publications
Regulation 30
Related Party Transactions
Regulation 47
Responsibility
Sustainability
CSR
EHS
Opportunities
Join Us
Careers
Contact Us
Location
SCO 850, Shivalik Enclave, Sector 13, NAC Manimajra, Chandigarh - 160101
Phone
0172-5061850
Email
support@indswiftlabs.com
Home
Disclaimer
Call us:
0172-5061850
Email us:
support@indswiftlabs.com
Regd. Office:
SCO 850, Shivalik Enclave, Sector 13, NAC Manimajra, Chandigarh - 160101
Home
About Us
Our Vision & Mission
Who We Are
Our History
Message from CMD-Desk
Our Leadership
People and Values
Our Values
Testimonials
Our Major Accreditations
Meet Our Team
Our Partners
Our Business
Ethical Business
Generic Healthcare Business
Export Business
Research & Development
Products
Ethical
Allopathic Medicine
General Health
Gynaecology
Pediatric
Ayurvedic Medicine
Generic
Agile
Healthcare
Capacities
Quality
Manufacturing
Global Business Unit
Samba Unit
Research & Development
Investor Relations
Disclosure under Regulation 46
Details of Business
MOA
Brief Profile of Directors
Composition of BOD
Composition of Committees
Corporate Goverance
Notice of Board Meetings
Financial Results (Quarterly)
Credit Rating
Audited Financial Results of Subsidiaries
Annual Returns
Notice of AGM/EGM
Notices
Annual Reports
Voting Results
Transcript
Business Responsiblity Reports
Shareholders Information
Shareholder Services
Unclamied Dividend
Details of Transfer under SEBI Circular
Amalgamation
Preferential Issue
Corporate Announcements
Integrated Corporate Goverance
Shareholding Pattern
Other Announcements
Publications
Regulation 30
Related Party Transactions
Regulation 47
Responsibility
Sustainability
CSR
EHS
Opportunities
Join Us
Careers
Contact Us
Home
About Us
Our Vision & Mission
Who We Are
Our History
Message from CMD-Desk
Our Leadership
People and Values
Our Values
Testimonials
Our Major Accreditations
Meet Our Team
Our Partners
Our Business
Ethical Business
Generic Healthcare Business
Export Business
Research & Development
Products
Ethical
Allopathic Medicine
General Health
Gynaecology
Pediatric
Ayurvedic Medicine
Generic
Agile
Healthcare
Capacities
Quality
Manufacturing
Global Business Unit
Samba Unit
Research & Development
Investor Relations
Disclosure under Regulation 46
Details of Business
MOA
Brief Profile of Directors
Composition of BOD
Composition of Committees
Corporate Goverance
Notice of Board Meetings
Financial Results (Quarterly)
Credit Rating
Audited Financial Results of Subsidiaries
Annual Returns
Notice of AGM/EGM
Notices
Annual Reports
Voting Results
Transcript
Business Responsiblity Reports
Shareholders Information
Shareholder Services
Unclamied Dividend
Details of Transfer under SEBI Circular
Amalgamation
Preferential Issue
Corporate Announcements
Integrated Corporate Goverance
Shareholding Pattern
Other Announcements
Publications
Regulation 30
Related Party Transactions
Regulation 47
Responsibility
Sustainability
CSR
EHS
Opportunities
Join Us
Careers
Contact Us
Disclosure U/r 30
Home
Investor Relations
Disclosure U/r 30
Intimation for Appointment of Senior Management Personnel
Click to view
NCLT, Chandigarh Bench sanctioning the Scheme of Arrangement for Amalgamation order dated 17.07.2025
Click to view
Intimation for re-constitution of Committees 04.07.2025
Click to view
Intimation for Appointment of Senior Management Personnel —
[Download 459Kb]
NCLT, Chandigarh Bench sanctioning the of Scheme of Arrangement for Amalgamation order dated 17.07.2025 —
[Download 413Kb]
Intimation for re-constitution of Committees 04.07.2025 —
[Download 428Kb]
Intimation under reg 30 for changes in Management 04.07.2025 —
[Download 477Kb]
Intimation under reg 24A ASCR for the year ended 31.03.2025 —
[Download 1.7 Mb]
Prior Intimation of Board meeting to be held on 30.05.2025 —
[Download 419Kb]
Outcome of board meeting 30.05.2025 —
[Download 715Kb]
Intimation on Arbitration proceeding 17.05.2025 —
[Download 421Kb]
Intimation of Receipt of “Best Employer Brand – Punjab 2025” Award —
[Download 865Kb]
Statement of Variation and Deviation 13.02.2025 —
[Download 565Kb]
Purchase of Land Intimation 01.01.2025 —
[Download 435Kb]
Outcome of the Board Meeting 13.02.2025 —
[Download 6.43Mb]
Notice of Board Meeting 06.02.2025 —
[Download 1.43Mb]
Notice of Adjournment of Board Meeting 12.02.2025 —
[Download 1.43Mb]
Compliance Certificate 74(5) 13.01.2025 —
[Download 1.90Mb]
Closure of Trading Window 26.12.2024 —
[Download 1.37Mb]
Cessation of Independent Director —
[Download 423kb]
Disclosure Regarding Purchase Of Land By The Company 09.12.2024 —
[Download 427kb]
Corrigendum To The Announcement 01.10.2024 ‘Disclosure Regarding Purchase Of Land By The Company’ —
[Download 436kb]
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 – 30.09.2024 —
[Download 3.7Mb]
Board Meeting Intimation – 06.11.2024 —
[Download 1.7Mb]
Outcome of Board Meeting 11.11.2024 —
[Download 3.7Mb]
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 – 16.07.2024 —
[Download 1.7Mb]
Board Meeting Intimation for Meeting To Be Held On Monday, Aug. 12, 2024 – 01.08.2024 —
[Download 1.9Mb]
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors 06.08.2024 —
[Download 3.10Mb]
Outcome of Board Meeting 12.08.2024 —
[Download 9.7Mb]
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s 12.08.2024 —
[Download 519Mb]
Intimation regarding Delisting of Non-Convertible Debentures from BSE Limited 13.08.2024 —
[Download 431Mb]
Disclosures Under Reg. 29(2) of SEBI (SAST) Regulations, 2011 – 03.09.2024 —
[Download 1.7Mb]
Intimation To Furnish Valid PAN, KYC Details & Nomination By Shareholders Holding Physical Shares 24.09.2024 —
[Download 1.69Mb]
Statement Of Deviation & Variation For The Quarter Ended 30.09.2024 – 11.11.2024 —
[Download 3.9Mb]
Intimation under Reg 30 (Announcement under Regulation 30 (LODR)-Updates on Acquisition) 18.05.2024 —
[Download 1.67Mb]
Outcome of Board Meeting 18.05.2024 —
[Download 1.91Mb]
Postal Ballot Outcome 22.06.2024 —
[Download 11.35Mb]
Intimation of Board Meeting and Closure of Trading Window 24.06.2024 —
[Download 1.5Mb]
Outcome of Board Meeting 27.06.2024 —
[Download 3.35Mb]
Outcome of Board Meeting 13.05.2024 —
[Download 5.6Mb]
Intimation regarding incorporation of Subsidiary —
[Download 1.58Mb]
Intimation under Regulation 10(6) of SEBI (SAST) —
[Download 1.81Mb]
Intimation under Regulation 29(2) of SAST, 2011 —
[Download 1.15Mb]
Intimation_Report under Regulation 10(7) —
[Download 7.59Mb]
Intimation_under_10_5_SAST —
[Download 2.53Mb]
Outcome of Board Meeting 30.03.2024 —
[Download 2.05Mb]
Intimation under Regulation 29(2) of SAST_2011 —
[Download 1.15Mb]
Amendment to the terms of BTA and Shareholders’ Agreement entered with Ms. Synthimed Labs —
[Download 478Kb]
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 —
[Download 680Kb]
Disclosures regarding the release of Pledge on the shares of the Company —
[Download 6.11Mb]
Disclosure Regarding Inter-Se Transfer Of The Shares Of The Company —
[Download 7.8Mb]
Early NCD Redemption Report —
[Download 431Kb]
Intimation of Receipt of “IDMA N.I. GANDHI – CHIEF MENTOR Award” —
[Download 1.34Mb]
Intimation regarding amendment in Agreement —
[Download 438Kb]
Intimation under Reg. 30- Completion of Slump Sale —
[Download 491Kb]
Intimation under Regulation 30-Change in KMP —
[Download 479Kb]
Disclosure under Regulation 30 A of SEBI (LODR), 2015 —
[Download 505Kb]
Receipt of North India’s Best Employer Award- 2023 —
[Download 637Kb]
Disclosure under Regulation 30(5) of SEBI(LODR), 2015 —
[Download 437Kb]
Collaboration with CSIR-IMTECH for Development of Biotransformation process —
[Download 582Kb]
Outcome of 28th AGM —
[Download 932Kb]
Re-appointment of Mrs. Neerja Chathley as Independent Director —
[Download 432Kb]
Ratification of appointment of Dr. Ashwani Kumar Vig beyond 75 years —
[Download 430Kb]
Intimation of EGM —
[Download 422Kb]
Outcome of EGM —
[Download 502Kb]
Re-appointment of Rishav Mehta as WTD —
[Download 705Kb]
Re-appointment of NR Munjal as Chairman & MD —
[Download 884Kb]
Re-appointment of Statutory Auditors —
[Download 783Kb]
Outcome of 27th AGM —
[Download 822Kb]
Re-appointment of Himanshu Jain as Jt. MD —
[Download 881Kb]
Notice of Book Closure for the Purpose of 27th AGM – 2022 —
[Download 107Kb]
Disclosure of Re-appointment of Statutory Auditor 10.08.2022 —
[Download 864Kb]
Disclosure of Re-appointment of Jt. Managing Director 10.08.2022 —
[Download 862Kb]
Disclosure of Re-appointment of Executive Director 10.08.2022 —
[Download 864Kb]
Disclosure of Re-appointment of Chairman & Managing Director 10.08.2022 —
[Download 849Kb]
Disclosure of Joint Venture 23.06.2022 —
[Download 544Kb]
Disclosure of Arbitration order 01.06.2022 —
[Download 147Kb]